A randomized, double-blind, placebo-controlled, single dose phase IIb exploratory study to document the clinical effects and safety of intra-articular injections of Lopain (MTX-071) in patients with chronic osteoarthritic knee joint pain (Part 1 and Part 3) and of higher doses or consecutive administrations with local anesthetics with exploratory pharmacokinetics (Part 2)
Latest Information Update: 08 Apr 2025
At a glance
- Drugs Resiniferatoxin (Primary)
- Indications Musculoskeletal pain
- Focus Therapeutic Use
- Sponsors Grunenthal; Mestex AG
Most Recent Events
- 20 Feb 2023 This trial has been completed in Slovakia (End Date: 26 Jan 2023) according to European Clinical Trials Database record.
- 26 Jan 2023 Status has been changed to completed.
- 21 Sep 2022 This trial has been completed in Croatia according to European Clinical Trials Database record.